Showing results (201-210 of 321) with videos related to

Sort By:
Pageof 33
Experimental Cell Research|December 1, 1994
Constitutive secretion of erythropoietin by human renal adenocarcinoma cells in vivo and in vitroM Shiramizu, Y Katsuoka, J Grodberg, et al.
Biological Psychiatry|September 1, 1987
RS 86 in the treatment of Alzheimer's disease: cognitive and biological effectsE Hollander, M Davidson, R C Mohs, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 23, 2000
Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patientsS R McGurk, P J Moriarty, P D Harvey, et al.
The American Journal of Psychiatry|November 4, 2000
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophreniaH M Ibrahim, A J Hogg, D J Healy, et al.
Biological Psychiatry|March 1, 1988
4-Aminopyridine in the treatment of Alzheimer's diseaseM Davidson, Z Zemishlany, R C Mohs, et al.
Dementia (Basel, Switzerland)|July 1, 1996
A pilot study of prednisone in Alzheimer's diseaseP S Aisen, D Marin, L Altstiel, et al.
American Journal of Medical Genetics|July 14, 1999
Genetic epidemiological study of maternal and paternal transmission of Alzheimer's diseaseD Ehrenkrantz, J M Silverman, C J Smith, et al.
Biological Psychiatry|February 25, 1998
Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disordersJ M Silverman, C J Smith, S L Guo, et al.
Archives of General Psychiatry|October 1, 1991
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrationsM Davidson, R S Kahn, P Knott, et al.
The American Journal of Psychiatry|June 1, 1996
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findingsR S Keefe, E Frescka, S H Apter, et al.
Pageof 33